EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Estudio de microbiota fecal revela disbiosis específica en espondiloartritis, según subtipo, actividad de la enfermedad y tratamiento

Consuelo Romero-Sánchez, Carlos Ferrer-Santos, Deisy Abril, Eduin Acosta-Hernández, Juliette De Ávila, Alejandro Ramos-Casallas, Javier Escobar, Wilson Bautista-Molano, Diego Jaimes, Adriana Beltrán-Ostos, Juan Manuel Bello-Gualtero, Cristian Flórez-Sarmiento und 2 weitere

Revista Alergia México · 2024

DOI: 10.29262/ram.v71i1.1305 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Revista Alergia México, 2024. Verfasst von Consuelo Romero-Sánchez und 13 weiteren Autor:innen. Beteiligte Einrichtung: Universidad Militar Nueva Granada, Facultad de Medicina, Programa de Reumatología, Grupo de Inmunología Clínica Aplicada, Bogotá, Colombia. Hauptthemen laut MEDLINE: Dysbiosis, Feces, Gastrointestinal Microbiome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 1 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Variability in microbiome composition and metabolic competence affects clinical activity and inflammatory status in spondyloarthritis-SpA.

Aim

To compare the diversity and composition of the gastrointestinal microbiome of patients with SpA.

Methods

MiSeq sequencing of the V3-V4 region of the 16S ribosomal RNA gene was performed on DNA isolated from stool. Patients with concurrent SpA and IBD were excluded. Differences were assessed for richness and diversity indices by QIIME 2™. Differences between means > 0.2% with a p-value < 0.05 were assumed significant. Institutional ethics committee endorsement.

Results

69 individuals included, 49 with SpA (ankylosing spondylitis-AS 72.9%, psoriatic arthritis-PsA 18.8%, reactive arthritis-ReA 8.3%) 5 positive controls-dysbiosis and 15 controls-eubiosis. Conventional treatment in 42.9%, anti-IL-17 16.3% and anti-TNF 40.8%. By subtype, statistically significant differences in favour of AS were found for the diversity indices. AS vs PsA there was a difference in favour of AS for Clostridium clostridioforme (p=0.002), Gemmiger formicilis (p=0.009), Roseburia inulivorans (p=0.008) and Lachnospira pectinoschiza. AS vs ReA there was a difference in favour of AS for L. pectinoschiza (p=0.009), Ruminococcus callidus (p=0.006), Clostridium ruminantium (p=0.031); G. formicilis (p=0.034). Diversity and richness showed differences in patients with high activity for Simpson's and Pielou's indices. In high activity, lower enrichment of Bacteroides eggerthii (p= 0.0003), C. ruminantium (p= 0.026) and Alistipes putredinis (p= 0.035) was found. The number of ASV was higher in the anti-IL-17 vs conventional group (p=0.025) and a trend between anti-IL-17 vs anti-TNF (p=0.09). In anti-TNF there was a lower proportion for C. clostridioforme (p=0.023), G. formicilis (p=0.030) and R. callidus (p= 0.003). In anti IL-17, Alistipes indistinctus (p= 0.012) was decreased.

Conclusions

There are differences in microbial diversity for SpA subtypes. The level of disease activity is plausible to influence the composition of the faecal microbiota. Anti-TNFα treatment may influence the microbiome environment favouring restoration of the gut microbiota, while anti-IL-17 may maintain an inflammatory environment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DysbiosisFecesGastrointestinal MicrobiomeHumansMaleFemaleAdultMiddle AgedProhibitinsSpondylarthritisSpondylitis, AnkylosingArthritis, PsoriaticArthritis, Reactive

Stichwörter der Autor:innen

Biological therapyDisease activityMicrobiomeSpondyloarthritis

Substanzen

Prohibitins

Autor:innen und Institutionen

  • Universidad Militar Nueva Granada, Facultad de Medicina, Programa de Reumatología, Grupo de Inmunología Clínica Aplicada, Bogotá, Colombia.
  • Universidad El Bosque, Grupo de Inmunología Celular y Molecular / INMUBO, Bogotá, Colombia.
  • Universidad Militar Nueva Granada, Programa de Medicina Interna, Bogotá, Colombia.
  • Laboratorio de Genética Molecular Bacteriana, Universidad El Bosque, Bogotá, Colombia.
  • Hospital Militar Central, Departamento de Reumatología e Inmunología, Grupo de Inmunología Clínica Aplicada, Bogotá, Colombia.
  • Clinicos IPS, Bogotá, Colombia.

Zitieren

APA

Romero-Sánchez, C., Ferrer-Santos, C., Abril, D., Acosta-Hernández, E., Ávila, J., Ramos-Casallas, A., Escobar, J., Bautista-Molano, W., Jaimes, D., Beltrán-Ostos, A., Bello-Gualtero, J. M., Flórez-Sarmiento, C., Parra-Izquierdo, V., & Calixto, O. J. (2024). Estudio de microbiota fecal revela disbiosis específica en espondiloartritis, según subtipo, actividad de la enfermedad y tratamiento. Revista Alergia México. https://doi.org/10.29262/ram.v71i1.1305

Vancouver

Romero-Sánchez C, Ferrer-Santos C, Abril D, Acosta-Hernández E, Ávila J, Ramos-Casallas A, et al. Estudio de microbiota fecal revela disbiosis específica en espondiloartritis, según subtipo, actividad de la enfermedad y tratamiento. Revista Alergia México. 2024. doi:10.29262/ram.v71i1.1305

BibTeX
@article{RomeroSnchez2024,
  author = {Romero-Sánchez, Consuelo and Ferrer-Santos, Carlos and Abril, Deisy and Acosta-Hernández, Eduin and Ávila, Juliette De and Ramos-Casallas, Alejandro and Escobar, Javier and Bautista-Molano, Wilson and Jaimes, Diego and Beltrán-Ostos, Adriana and Bello-Gualtero, Juan Manuel and Flórez-Sarmiento, Cristian and Parra-Izquierdo, Viviana and Calixto, Omar Javier},
  title = {Estudio de microbiota fecal revela disbiosis específica en espondiloartritis, según subtipo, actividad de la enfermedad y tratamiento},
  journal = {Revista Alergia México},
  year = {2024},
  doi = {10.29262/ram.v71i1.1305}
}
Kostenlos starten →